Control of cardiac growth by histone acetylation/deacetylation

被引:446
作者
Backs, J [1 ]
Olson, EN [1 ]
机构
[1] Univ Texas, SW Med Ctr, Dept Biol Mol, Dallas, TX 75390 USA
关键词
cardiac hypertrophy; histone acetyltransferase; histone deacetylase; gene expression; epigenetics;
D O I
10.1161/01.RES.0000197782.21444.8f
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Histones control gene expression by modulating the structure of chromatin and the accessibility of regulatory DNA sequences to transcriptional activators and repressors. Posttranslational modifications of histones have been proposed to establish a "code" that determines patterns of cellular gene expression. Acetylation of histones by histone acetyltransferases stimulates gene expression by relaxing chromatin structure, allowing access of transcription factors to DNA, whereas deacetylation of histones by histone deacetylases promotes chromatin condensation and transcriptional repression. Recent studies demonstrate histone acetylation/deacetylation to be a nodal point for the control of cardiac growth and gene expression in response to acute and chronic stress stimuli. These findings suggest novel strategies for "transcriptional therapies" to control cardiac gene expression and function. Manipulation of histone modifying enzymes and the signaling pathways that impinge on them in the settings of pathological cardiac growth, remodeling, and heart failure represents an auspicious therapeutic approach.
引用
收藏
页码:15 / 24
页数:10
相关论文
共 117 条
[1]
Silent information regulator 2α, a longevity factor and class III histone deacetylase, is an essential endogenous apoptosis inhibitor in cardiac myocytes [J].
Alcendor, RR ;
Kirshenbaum, LA ;
Imai, S ;
Vatner, SF ;
Sadoshima, J .
CIRCULATION RESEARCH, 2004, 95 (10) :971-980
[2]
ALLIS CD, 2004, CHROMATIN CHROMATIN
[3]
Activated glycogen synthase-3β suppresses cardiac hypertrophy in vivo [J].
Antos, CL ;
McKinsey, TA ;
Frey, N ;
Kutschke, W ;
McAnally, J ;
Shelton, JM ;
Richardson, JA ;
Hill, JA ;
Olson, EN .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (02) :907-912
[4]
Dose-dependent blockade to cardiomyocyte hypertrophy by histone deacetylase inhibitors [J].
Antos, CL ;
McKinsey, TA ;
Dreitz, M ;
Hollingsworth, LM ;
Zhang, CL ;
Schreiber, K ;
Rindt, H ;
Gorczynski, RJ ;
Olson, EN .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (31) :28930-28937
[5]
Network integration of the adrenergic system in cardiac hypertrophy [J].
Barki-Harrington, L ;
Perrino, C ;
Rockman, HA .
CARDIOVASCULAR RESEARCH, 2004, 63 (03) :391-402
[6]
Learning from failure: congestive heart failure in the postgenomic age [J].
Benjamin, IJ ;
Schneider, MD .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (03) :495-499
[7]
A small molecular activator of cardiac hypertrophy uncovered in a chemical screen for modifiers of the calcineurin signaling pathway [J].
Bush, E ;
Fielitz, J ;
Melvin, L ;
Martinez-Arnold, M ;
McKinsey, TA ;
Plichta, R ;
Olson, EN .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (09) :2870-2875
[8]
Modulation of smooth muscle gene expression by association of histone acetyltransferases and deacetylases with myocardin [J].
Cao, DS ;
Wang, ZG ;
Zhang, CL ;
Oh, J ;
Xing, WB ;
Li, SJ ;
Richardson, JA ;
Wang, DZ ;
Olson, EN .
MOLECULAR AND CELLULAR BIOLOGY, 2005, 25 (01) :364-376
[9]
Induction of interferon-stimulated gene expression and antiviral responses require protein deacetylase activity [J].
Chang, HM ;
Paulson, M ;
Holko, M ;
Rice, CM ;
Williams, BRG ;
Marié, I ;
Levy, DE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (26) :9578-9583
[10]
An expression screen reveals modulators of class II histone deacetylase phosphorylation [J].
Chang, SR ;
Bezprozvannaya, S ;
Li, SJ ;
Olson, EN .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (23) :8120-8125